Tamotsu Tsukahara joined Dr. Gabor Tigyi Lab at the University of Tennessee Health Science Center, Memphis, TN, USA, for his first postdoctoral studies after completing his Ph.D. degree at Hokkaido University, Sapporo, Japan, in 2002. During his postdoctoral work, he began characterizing the novel lipid molecule that targets PPARγ for the treatment of plaque-related diseases such as atherosclerosis, high blood pressure, and coronary artery disease. He has been exposed to many cutting-edge techniques in collaboration with Dr. Daniel Baker at the University of Memphis, Memphis, TN, USA. From 2008 to 2013, he served as an Assistant Professor of physiology at the School of Medicine at the Shinshu University, Matsumoto, Japan. He received selected awards and honors such as an award from Astellas Foundation for Research on Metabolic Disorders (2010), Takeda Science Foundation (2011), and Daiwa Securities Health Foundation (2014). He has authored more than 40 peer-reviewed publications in Molecular Cell, The Journal of Biological Chemistry, Molecular and Cellular Endocrinology, and PLOS ONE. His major goal is to discover antagonist of PPARγ and its characterization that inhibits foam cell and neointima formation. He is currently acting as an Associate Professor at the Nagasaki University, Nagasaki, Japan.
Biography Updated on 4 June 2015